Randomized, placebo-controlled study of Lamifiban with thrombolytic therapy for the treatment of acute myocardial infarction: Rationale and design for the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) study
David J. Moliterno, Robert A. Harrington, Robert M. Califf, Hans J. Rapold, Eric J. Topol
Research output: Contribution to journal › Article › peer-review
23Scopus
citations
Fingerprint
Dive into the research topics of 'Randomized, placebo-controlled study of Lamifiban with thrombolytic therapy for the treatment of acute myocardial infarction: Rationale and design for the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) study'. Together they form a unique fingerprint.